Delivery Order SPE2DB20D1100-SPE2DB25FE0TS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count) under a firm fixed-price contract type. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of August 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,025.75 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of July 23, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery. This delivery order operates...
- The Defense Logistics Agency has awarded a delivery order valued at $1,733.32 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90 count) under a firm fixed price contract. This non-set-aside award, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,762.37 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count packaging). The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of September 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. This delivery order is executed under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,092.47 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract. This non-set-aside award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a single delivery order fulfillment for pharmaceutical supplies to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract type. The order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing prime contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $4,911.57 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count units) under a firm fixed-price contract. The award was made on September 23, 2025, with an ultimate completion date of September 24, 2025, and represents a non-set-aside, competitively awarded procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,939.44 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count packages) under a firm fixed price contract type. The award, dated September 25, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,715.55 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count packages) under a firm fixed price contract type. This non-set-aside award was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, and the place of performance...
- The Defense Logistics Agency awarded a delivery order valued at $3,638.40 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (30-count units) under a firm fixed-price contract. The award was announced on May 30, 2025, with an ultimate completion date of June 2, 2025. This delivery order represents a non-set-aside, competitively awarded transaction executed through AmerisourceBergen's existing contract vehicle with the DLA. The place of performance is AmerisourceBergen's...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0TSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,689.33 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside designation and carries an ultimate completion date of September 23, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The arrangement provides the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with access to specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/22/25 |